A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4164 (2006.01) A61K 31/4192 (2006.01) A61K 31/44 (2006.01) C07D 213/70 (2006.01)
Patent
CA 2584598
The present invention is directed to compounds which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.
La présente invention se rapporte à des composés qui sont des potentialisateurs des récepteurs métabotropiques du glutamate, notamment du récepteur mGluR2, et qui sont utiles pour le traitement ou la prévention des troubles neurologiques et psychiatriques associés à un dysfonctionnement du glutamate et à des maladies dans lesquelles sont impliquées les récepteurs métabotropiques du glutamate. L'invention se rapporte également à des compositions pharmaceutiques comportant ces composés, ainsi qu'à l'utilisation de ces composés et compositions pour la prévention et le traitement des maladies dans lesquelles sont impliquées les récepteurs métabotropiques du glutamate.
Cube Rowena V.
Hutchinson John H.
Pinkerton Anthony B.
Vernier Jean-Michel
Merck & Co. Inc.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Heterocyclic indanone potentiators of metabotropic glutamate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic indanone potentiators of metabotropic glutamate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic indanone potentiators of metabotropic glutamate... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2020343